The National Office of
Public Health Genomics
presented:
Thursday, March 29,
2007
1:00 – 3:00 p.m.
In 2006, the National Office of Public Health Genomics (NOPHG)
started the Public Health Genomics Collaboration (PHGC),
a network of CDC professionals working or interested in
public health genomics. The goals of this collaboration
are to:
- provide a forum for the ongoing
exchange of ideas and information,
- determine points of synergy for
improving health impact by using genomics to
address CDC goals, and
- integrate public health genomics into
research, policy, and programs across CDC.
On March 29, 2007, NOPHG hosted its third PHGC meeting on March 29, 2007. Kathleen Toomey, MD, MPH, the new director of
the Coordinating Center for Health Promotion (CoCHP),
started the meeting with welcoming remarks. Muin
Khoury, PhD, MD, director of NOPHG, provided an
overview of public health genomics at CDC, and Scott
Bowen, MPH, deputy director of NOPHG, provided an
overview of the public health genomics seed funding
projects. This meeting included presentations from
three selected public health genomics seed funding
projects, followed by a presentation on best practices
for protecting human subjects in public health genomics
research.
The full meeting agenda can be viewed below. Links to presentation slides will be added to
the agenda as they become available.
Welcoming Remarks
|
Kathleen Toomey, MD, MPH
Director, Coordinating Center for Health Promotion, CDC |
Public Health Genomics 2007 at CDC
|
Muin Khoury, PhD, MD
Director, National Office of Public Health Genomics, CDC View presentation |
New Public Health Genomics Training Opportunity and Overview of Seed Funding Projects
|
Scott Bowen, MPH
Deputy Director, National Office of Public Health Genomics, CDC |
Maternal Smoking, Polymorphisms of Genes
Involved with Metabolism of Tobacco Smoke,& Risk
for Gastroschisis and Anorectal Atresia/Stenosis
|
Margaret Honein, PhD, MPH
National Center for Birth Defects and Developmental Disabilities, CDC |
Identifying Genetic Determinants of Susceptibility
to M. Tuberculosis
|
Mary Reichler, MD, MPH
National Center for HIV, Viral Hepatitis, STD, and TB Prevention, CDC |
Microarray Analyses of MHC Genetic Variations
in Diisocyanate-Induced Occupational Asthma
|
Michael Luster, PhD
National Institute for Occupational Safety and Health (NIOSH) |
Best practices for protecting human subjects
in public health genomics research
|
Mary Leinhos, PhD
National Office of Public Health Genomics, CDC View presentation |
Closing remarks and discussion |
|
|